Contineum Therapeutics Q1 2025: Assets $200M, OpEx $6.7M
Ticker: CTNM · Form: 10-Q · Filed: May 14, 2025 · CIK: 1855175
| Field | Detail |
|---|---|
| Company | Contineum Therapeutics, Inc. (CTNM) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Contineum Therapeutics Q1 2025: $200M assets, $6.7M operating cash burn.
AI Summary
Contineum Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported total assets of $200,000,000 and total liabilities of $19,142,377. Net cash used in operating activities was $6,729,172 for the three months ended March 31, 2025.
Why It Matters
This filing provides a snapshot of Contineum Therapeutics' financial health and operational spending in early 2025, crucial for investors assessing its burn rate and asset base.
Risk Assessment
Risk Level: medium — The company has significant assets but also shows substantial operating expenses, indicating a need for continued funding or revenue generation.
Key Numbers
- $200.0B — Total Assets (As of March 31, 2025)
- $19.1M — Total Liabilities (As of March 31, 2025)
- $6.7M — Net Cash Used in Operations (For the three months ended March 31, 2025)
Key Players & Entities
- Contineum Therapeutics, Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of reporting period
- $200,000,000 (dollar_amount) — Total assets
- $19,142,377 (dollar_amount) — Total liabilities
- $6,729,172 (dollar_amount) — Net cash used in operating activities for Q1 2025
FAQ
What was Contineum Therapeutics' net cash used in operating activities for the three months ended March 31, 2025?
The net cash used in operating activities for the three months ended March 31, 2025, was $6,729,172.
What were the total assets of Contineum Therapeutics as of March 31, 2025?
Contineum Therapeutics reported total assets of $200,000,000 as of March 31, 2025.
What were the total liabilities of Contineum Therapeutics as of March 31, 2025?
Contineum Therapeutics reported total liabilities of $19,142,377 as of March 31, 2025.
What was the previous company name for Contineum Therapeutics?
The former company name was Pipeline Therapeutics, Inc., with a date of name change on April 5, 2021.
What is the business address for Contineum Therapeutics?
The business address is 3565 General Atomics Court, Suite 200, San Diego, CA 92121.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Contineum Therapeutics, Inc. (CTNM).